The Biotechnology Innovation Organization (BIO) provides a glimpse of economic development in the biosciences ecosystem at the state and regional levels. The report, which was developed in partnership with the Council of State Bioscience Associations (CSBA), was released as an industry analysis in the wake of the COVID-19 pandemic and its impact on the overall economy.
BIO and TEConomy Partners released their 2018 “Investment, Innovation and Job Creation in a Growing U.S. Bioscience Industry” report.
The supply of life-saving medicines in Europe could be severely disrupted unless Britain successfully negotiates a smooth and orderly exit from the EU, pharmaceutical industry leaders warned.
Initial commitment toward a larger 10-year plan will create group to explore and fund frontiers in bioscience WASHINGTON, March 23, 2016 /PRNewswire-USNewswire/ — Philanthropist and entrepreneur Paul G. Allen today announced an initial commitment of $100 million to create The Paul G. Allen Frontiers Group, whose purpose will be to explore the landscape of […]